Trial Profile
Randomized Crossover Trial of Fycompa in the Treatment of Pain Associated With Small Fiber Neuropathy (SFN)
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Jan 2018
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 26 Jan 2016 Planned End Date changed from 1 Jan 2016 to 1 Dec 2016, according to ClinicalTrials.gov record.
- 26 Jan 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Dec 2016, according to ClinicalTrials.gov record.
- 26 Jan 2016 Status changed from not yet recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.